NEW YORK (Reuters Health) Jul 13 - Inhaled human insulin (Exubera) provides glycemic control comparable to that with subcutaneous insulin with only minor, reversible effects on pulmonary function, according to findings published in the June issue of The Journal of Clinical Endocrinology & Metabolism.
http://www.health-sky.com/html/excited-news-for-diabetes-away-from-needle.html
This News reliable?
2007-07-23
05:02:36
·
8 answers
·
asked by
goinlove
2
in
Health
➔ Diseases & Conditions
➔ Diabetes